ABS-CBN
Remulla orders withdrawal of unarraigned Pharmally cases in Sandiganbayan
The Office of the Ombudsman has ordered the withdrawal of Pharmally-related cases that have yet to undergo arraignment from the Sandiganbayan for reassessment.
Ombudsman Jesus Crispin Remulla stated that the cases need to be thoroughly reviewed to ensure they are trial-ready once refiled.
Remulla cited a lack of continuity and segregation in how the cases were handled previously, with different functions not connected to each other.
The Pharmally scandal involved P4.4 billion in medical supplies procured in 2020 from Pharmally corporation.
The Ombudsman intends to seek help from former Senator Richard Gordon, who led the Senate Blue Ribbon Committee that investigated the scandal, in revisiting the anomalous procurement.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
Newly-appointed Ombudsman Jesus Crispin Remulla announced his intention to review the P4.4 billion Pharmally scandal, stating it seemed to have been "forgotten" and should not be.
Read more →
Incoming Ombudsman Jesus Crispin Remulla aims to file corruption cases related to flood control projects before the Sandiganbayan by November.
+2
Read more →
Justice Secretary Jesus Crispin "Boying" Remulla has been appointed as the new Ombudsman, succeeding Samuel Martires.
+4
Read more →